KRTL BioTech

'Shark Tank' investor Kevin O'Leary: '20% of my small private portfolio' of companies will fail

'Shark Tank' investor Kevin O'Leary: '20% of my small private portfolio' of companies will fail

"They have to die, because the consumer is moving into a different direction," Kevin O'Leary told CNBC.